Rare Diseases

There are nearly 7,000 rare diseases that have been identified, many resulting from a single defective gene. But because each individual rare disease may not affect a wide swath of the population, many do not receive the same degree of investment and research that drug producers dedicate to more widespread diseases.

DCANS Healthcare aims to accelerate the search for rare disease treatments by partnering with others in automating the process by which cellular biology experiments are prepared and analysed. Through advanced robotics, computer vision and machine-learning software, we can run experiments for and perform analysis on hundreds of diseases simultaneously.